BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30292919)

  • 1. Role of Skin Tests in the Diagnosis of Immediate Hypersensitivity Reactions to Taxanes: Results of a Multicenter Study.
    Pagani M; Bavbek S; Dursun AB; Bonadonna P; Caralli M; Cernadas J; Cortellini G; Costantino MT; Gelincik A; Lucchini G; Castells M
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):990-997. PubMed ID: 30292919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hypersensitivity Reactions to Taxanes.
    Picard M
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
    Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
    J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions.
    Lansinger OM; Biedermann S; He Z; Colevas AD
    J Clin Oncol; 2021 Nov; 39(32):3583-3590. PubMed ID: 34357780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity Reactions to Platinum Agents and Taxanes.
    Tsao LR; Young FD; Otani IM; Castells MC
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions.
    Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A
    J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
    Goksel O; Goksel T; Cok G; Karakus H; Bacakoglu F; Goker E; Uslu R; Erdinc M
    Int J Clin Oncol; 2015 Apr; 20(2):395-404. PubMed ID: 25056643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel as an alternative to paclitaxel after acute hypersensitivity reactions.
    Bernstein BJ
    Ann Pharmacother; 2000 Nov; 34(11):1332-5. PubMed ID: 11098349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
    Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences.
    Bulut İ; Yegin Katran Z
    Int Arch Allergy Immunol; 2023; 184(9):849-855. PubMed ID: 37442106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
    Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
    J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
    Limsuwan T; Castells MC
    Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to tetracyclines: Skin testing, graded challenge, and desensitization regimens.
    Maciag MC; Ward SL; O'Connell AE; Broyles AD
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):589-593. PubMed ID: 32087343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes.
    Ratanajarusiri T; Sriuranpong V; Sitthideatphaiboon P; Poovoravan N; Vinayanuwat C; Parinyanitikul N; Angspatt P; Thawinwisan W; Tanasanvimon S
    Chemotherapy; 2017; 62(2):134-139. PubMed ID: 27997900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
    Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and management of antineoplastic-induced hypersensitivity reactions.
    Zanotti KM; Markman M
    Drug Saf; 2001; 24(10):767-79. PubMed ID: 11676304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.